D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians

European Archives of Psychiatry and Clinical Neuroscience

Volumn 262, Issue 7, 2012, Pages 549-556

  Andreou, Dimitrios ^a   Saetre, Peter ^a   Werge, Thomas ^b   Andreassen, Ole A ^c,d   Agartz, Ingrid ^a,d,e   Sedvall, Göran C ^a   Hall, Håkan ^a,f   Terenius, Lars ^a   Jönsson, Erik G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Mental Health Services CPH   (Denmark)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e DIAKONHJEMMET HOSPITAL   (Norway)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

3 methoxy 4 hydroxyphenylglycol (MHPG); 5 hydroxyindoleacetic acid (5 HIAA); Cerebrospinal fluid (CSF); D amino acid oxidase activator gene (DAOA); Homovanillic acid (HVA)

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DEXTRO AMINO ACID OXIDASE; GENOMIC DNA; HOMOVANILLIC ACID; MONOAMINE;

ADULT; ARTICLE; CATALYSIS; CAUCASIAN; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; ENZYME ACTIVITY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HIPPOCAMPUS; HUMAN; LONGITUDINAL STUDY; LUMBAR PUNCTURE; MALE; METABOLITE; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; D-AMINO-ACID OXIDASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HOMOVANILLIC ACID; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84867988140     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-012-0313-z     Document Type: Article

References (53)

1. Adams BW, Bradberry CW, Moghaddam B (2002) NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys. Synapse 43:12-18 (Pubitemid 33115663)
2. Allen NC, Bagade S, McQueen MB, Ioannidis JPA, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L (2008) Systematic metaanalyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 40:827-834 (Pubitemid 351913655)
3. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265 (Pubitemid 40202029)
4. Bass NJ, Datta SR, McQuillin A, Puri V, Choudhury K, Thirumalai S, Lawrence J, Quested D, Pimm J, Curtis D, Gurling HM (2009) Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia. Behav Brain Funct 5:28
5. Beuger M, van Kammen DP, Kelley ME, Yao J (1996) Dopamine turnover in schizophrenia before and after haloperidol withdrawal. Neuropsychopharmacology 15:75-86 (Pubitemid 26233393)
6. Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel F-A (1985) Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry 147:276-282 (Pubitemid 16255918)
7. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, Bougueleret L, Barry C, Tanaka H, La Rosa P, Puech A, Tahri N, Cohen-Akenine A, Delabrosse S, Lissarrague S, Picard FP, K M, Essioux L, Millasseau P, Grel P, Debailleul V, Simon AM, Caterina D, Dufaure I, Malekzadeh K, Belova M, Luan JJ, Bouillot M, Sambucy JL, Primas G, Saumier M, Boubkiri N, Martin-Saumier S, Nasroune M, Peixoto H, Delaye A, Pinchot V, Bastucci M, Guillou S, Chevillon M, Sainz-Fuertes R, Meguenni S, Aurich-Costa J, Cherif D, Gimalac A, Van Duijn C, Gauvreau D, Ouellette G, Fortier I, Raelson J, Sherbatich T, Riazanskaia N, Rogaev E, Raeymaekers P, Aerssens J, Konings F, Luyten W, Macciardi F, Sham PC, Straub RE, Weinberger DR, Cohen N, Cohen D (2002) Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 99:13675-13680 (Pubitemid 35215440)
8. Dalvie S, Horn N, Nossek C, van der Merwe L, Stein DJ, Ramesar R (2010) Psychosis and relapse in bipolar disorder are related to GRM3, DAOA, and GRIN2B genotype. Afr J Psychiatry (Johannesbg) 13:297-301
9. Feldman S, Weidenfeld J (2004) Involvement of endogeneous glutamate in the stimulatory effect of norepinephrine and serotonin on the hypothalamo-pituitary-adrenocortical axis. Neuroendocrinology 79:43-53 (Pubitemid 38186452)
10. Fiorentini C, Gardoni F, Spano P, Di Luca M, Missale C (2003) Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J Biol Chem 278:20196-20202 (Pubitemid 36799216)
11. French ED (1994) Phencyclidine and the midbrain dopamine system: electrophysiology and behavior. Neurotoxicol Teratol 16:355-362 (Pubitemid 24269731)
12. Geijer T, Neiman J, Rydberg U, Gyllander A, Jönsson E, Sedvall G, Valverius P, Terenius L (1994) Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur Arch Psychiatry Clin Neurosci 244:26-32 (Pubitemid 24189931)
13. Geracioti TD Jr, Keck PE Jr, Ekhator NN, West SA, Baker DG, Hill KK, Bruce AB, Wortman MD (1998) Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid. Biol Psychiatry 44:228-233 (Pubitemid 28378304)
14. Goldberg TE, Straub RE, Callicott JH, Hariri A, Mattay VS, Bigelow L, Coppola R, Egan MF, Weinberger DR (2006) The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 31:2022-2032
15. Hall J, Whalley HC, Moorhead TW, Baig BJ, McIntosh AM, Job DE, Owens DG, Lawrie SM, Johnstone EC (2008) Genetic variation in the DAOA (G72) gene modulates hippocampal function in subjects at high risk of schizophrenia. Biol Psychiatry 64:428-433
16. Hartz SM, Ho BC, Andreasen NC, Librant A, Rudd D, Epping EA, Wassink TH (2010) G72 influences longitudinal change in frontal lobe volume in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 153B:640-647
17. Higley JD, Mehlman PT, Higley SB, Fernald B, Vickers J, Lindell SG, Taub DM, Suomi SJ, Linnoila M (1996) Excessive mortality in young free-ranging male nonhuman primates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. Arch Gen Psychiatry 53:537-543 (Pubitemid 26175573)
18. Higley JD, Thompson WW, Champoux M, Goldman D, Hasert MF, Kraemer GW, Scanlan JM, Suomi SJ, Linnoila M (1993) Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta). Arch Gen Psychiatry 50:615-623 (Pubitemid 23229270)
19. Johnson JW, Ascher P (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325:529-531 (Pubitemid 17056733)
20. Jonsson EG, Saetre P, Edman-Ahlbom B, Sillen A, Gunnar A, Andreou D, Agartz I, Sedvall G, Hall H, Terenius L (2008) Brainderived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers. J Neural Transm 115:1695-1699
21. Jonsson EG, Saetre P, Vares M, Andreou D, Larsson K, Timm S, Rasmussen HB, Djurovic S, Melle I, Andreassen OA, Agartz I, Werge T, Hall H, Terenius L (2009) DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study. Neuropsychobiology 59:142-150
22. Jönsson E, Sedvall G, Brené S, Gustavsson JP, Geijer T, Terenius L, Crocq M-A, Lannfelt L, Tylec A, Sokoloff P, Schwartz JC, Wiesel F-A (1996) Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol Psychiatry 40:1032-1043 (Pubitemid 26391681)
23. Jönsson EG, Bah J, Melke J, Abou Jamra R, Schumacher J, Westberg L, Ivo R, Cichon S, Propping P, Nöthen MM, Eriksson E, Sedvall GC (2004) Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers. BMC Psychiatry 4:4
24. Kawazoe T, Park HK, Iwana S, Tsuge H, Fukui K (2007) Human D-amino acid oxidase: an update and review. Chem Rec 7:305-315
25. Korostishevsky M, Kaganovich M, Cholostoy A, Ashkenazi M, Ratner Y, Dahary D, Bernstein J, Bening-Abu-Shach U, Ben-Asher E, Lancet D, Ritsner M, Navon R (2004) Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol Psychiatry 56:169-176 (Pubitemid 38969149)
26. Kotaka T, Ujike H, Okahisa Y, Takaki M, Nakata K, Kodama M, Inada T, Yamada M, Uchimura N, Iwata N, Sora I, Iyo M, Ozaki N, Kuroda S (2009) G72 gene is associated with susceptibility to methamphetamine psychosis. Prog Neuropsychopharmacol Biol Psychiatry 33:1046-1049
27. Krug A, Markov V, Krach S, Jansen A, Zerres K, Eggermann T, Stocker T, Shah NJ, Nothen MM, Georgi A, Strohmaier J, Rietschel M, Kircher T (2011) Genetic variation in G72 correlates with brain activation in the right middle temporal gyrus in a verbal fluency task in healthy individuals. Hum Brain Mapp 32:118-126
28. Kvajo M, Dhilla A, Swor DE, Karayiorgou M, Gogos JA (2008) Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Mol Psychiatry 13:685-696 (Pubitemid 351861528)
29. Lee FJ, Xue S, Pei L, Vukusic B, Chery N, Wang Y, Wang YT, Niznik HB, Yu XM, Liu F (2002) Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 111:219-230 (Pubitemid 35292442)
30. Missale C, Fiorentini C, Busi C, Collo G, Spano PF (2006) The NMDA/D1 receptor complex as a new target in drug development. Curr Top Med Chem 6:801-808
31. Mossner R, Schuhmacher A, Wagner M, Quednow BB, Frommann I, Kuhn KU, Schwab SG, Rietschel M, Falkai P, Wolwer W, Ruhrmann S, Bechdolf A, Gaebel W, Klosterkotter J, Maier W (2010) DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis. Eur Arch Psychiatry Clin Neurosci 260:209-215
32. Mothet JP, Parent AT, Wolosker H, Brady RO Jr, Linden DJ, Ferris CD, Rogawski MA, Snyder SH (2000) D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 97:4926-4931 (Pubitemid 30238659)
33. Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathe AA (2010) Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF. J Clin Psychopharmacol 30:496-503
34. Otte DM, Bilkei-Gorzo A, Filiou MD, Turck CW, Yilmaz O, Holst MI, Schilling K, Abou-Jamra R, Schumacher J, Benzel I, Kunz WS, Beck H, Zimmer A (2009) Behavioral changes in G72/G30 transgenic mice. Eur Neuropsychopharmacol 19:339-348
35. Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G (1986) Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals - a genetic study. J Psychiatr Res 20:19-29 (Pubitemid 16138075)
36. Pae CU, Chiesa A, Serretti A (2010) Influence of DAOA gene variants on antipsychotic response after switch to aripiprazole. Psychiatry Res 178:430-432
37. Pei L, Lee FJ, Moszczynska A, Vukusic B, Liu F (2004) Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. J Neurosci 24:1149-1158 (Pubitemid 38177022)
38. Prata D, Breen G, Osborne S, Munro J, St Clair D, Collier D (2008) Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 147B:914-917
39. Rao TS, Kim HS, Lehmann J, Martin LL, Wood PL (1989) Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivo. Life Sci 45:1065-1072 (Pubitemid 19229493)
40. Rietschel M, Beckmann L, Strohmaier J, Georgi A, Karpushova A, Schirmbeck F, Boesshenz KV, Schmal C, Burger C, Jamra RA, Schumacher J, Hofels S, Kumsta R, Entringer S, Krug A, Markov V, Maier W, Propping P, Wust S, Kircher T, Nothen MM, Cichon S, Schulze TG (2008) G72 and its association with major depression and neuroticism in large population-based groups from Germany. Am J Psychiatry 165:753-762 (Pubitemid 351810545)
41. Rogers J, Martin LJ, Comuzzie AG, Mann JJ, Manuck SB, Leland M, Kaplan JR (2004) Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid. Biol Psychiatry 55:739-744 (Pubitemid 38376186)
42. Sacchi S, Bernasconi M, Martineau M, Mothet JP, Ruzzene M, Pilone MS, Pollegioni L, Molla G (2008) pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility. J Biol Chem 283:22244-22256
43. Scheepers FE, Gispen-de Wied CC, Westenberg HG, Kahn RS (2001) The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients. Neuropsychopharmacology 25:468-475 (Pubitemid 32830951)
44. Scott L, Kruse MS, Forssberg H, Brismar H, Greengard P, Aperia A (2002) Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation. Proc Natl Acad Sci USA 99:1661-1664 (Pubitemid 34136549)
45. Sedvall GC, Wode-Helgodt B (1980) Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients. Arch Gen Psychiatry 37:1113-1116 (Pubitemid 10015014)
46. Smith SM, Uslaner JM, Yao L, Mullins CM, Surles NO, Huszar SL, McNaughton CH, Pascarella DM, Kandebo M, Hinchliffe RM, Sparey T, Brandon NJ, Jones B, Venkatraman S, Young MB, Sachs N, Jacobson MA, Hutson PH (2009) The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine. J Pharmacol Exp Ther 328:921-930
47. Swahn C-G, Sandgärde B, Wiesel F-A, Sedvall G (1976) Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method. Psychopharmacology 48:147-152
48. Vasic N, Connemann BJ, Wolf RC, Tumani H, Brettschneider J (2011) Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand? Eur Arch Psychiatry Clin Neurosci. doi: 10.1007/s00406-00011-00280-00409
49. Wheeler D, Boutelle MG, Fillenz M (1995) The role of N-methyl-D-aspartate receptors in the regulation of physiologically released dopamine. Neuroscience 65:767-774
50. Wieselgren I-M, Lindström LH (1998) CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia. Psychiatry Res 81:101-110 (Pubitemid 28526966)
51. Wigginton JE, Abecasis GR (2005) PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 21:3445-3447 (Pubitemid 41222458)
52. Wu M, Zhou XJ, Konno R, Wang YX (2006) D-dopa is unidirectionally converted to L-dopa by D-amino acid oxidase, followed by dopa transaminase. Clin Exp Pharmacol Physiol 33:1042-1046 (Pubitemid 44581565)
53. Zuliani R, Moorhead TW, Job D, McKirdy J, Sussmann JE, Johnstone EC, Lawrie SM, Brambilla P, Hall J, McIntosh AM (2009) Genetic variation in the G72 (DAOA) gene affects temporal lobe and amygdala structure in subjects affected by bipolar disorder. Bipolar Disord 11:621-627